Nancy Valente
Impact in
- Genetics top 1%
- Chronic Lymphocytic Leukemia Research
- Hematology top 1%
- Hemophilia Treatment and Research
- Platelet Disorders and Treatments
- Blood Coagulation and Thrombosis Mechanisms
Papers in
- Genetics 7
- Chronic Lymphocytic Leukemia Research 7
-
- Lymphoma Diagnosis and Treatment 7
- Co-authors
- Michael Wenger (4 shared papers)Amy Hobeika (1 shared paper)H. Kim Lyerly (1 shared paper)Alain Delcayre (1 shared paper)Revati Shreeniwas (1 shared paper)Michael A. Morse (1 shared paper)Timothy M. Clay (1 shared paper)Takuya Osada (1 shared paper)
- Journals
- Blood (4 papers)Journal of Clinical Oncology (2 papers)Journal of Translational Medicine (1 paper)The Journal of Clinical Pharmacology (1 paper)New England Journal of Medicine (1 paper)
- Partner nations
- United StatesSwitzerlandFrance
In The Last Decade
Nancy Valente
12 papers receiving 2.5k citations
Nancy Valente's Hit Papers
Peers
Comparison fields: 5 of 86
- Genetics 768
- Hematology 803
- Cancer Research 520
- Pathology and Forensic Medicine 559
- Immunology 642
Countries citing papers authored by Nancy Valente
This map shows the geographic impact of Nancy Valente's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nancy Valente with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nancy Valente more than expected).
Fields of papers citing papers by Nancy Valente
This network shows the impact of papers produced by Nancy Valente. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nancy Valente. The network helps show where Nancy Valente may publish in the future.
Co-authors
The 25 scholars most cited alongside Nancy Valente, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | A phase I study of dexosome immunotherapy in patients with advanced non-small cell lung cancer Hit paper breakdown → | 2005 | 917 |
| 2 | Emicizumab Prophylaxis in Hemophilia A with Inhibitors Hit paper breakdown → | 2017 | 759 |
| 3 | Rituximab in B-Cell Hematologic Malignancies: A Review of 20 Years of Clinical Experience Hit paper breakdown → | 2017 | 396 |
| 4 | 2010 | 358 | |
| 5 | 2012 | 64 | |
| 6 | 2008 | 40 | |
| 7 | 2007 | 19 | |
| 8 | 2015 | 11 | |
| 9 | Iodine I 131 tositumomab for patients with low-grade or transformed low-grade NHL: Complete response data. | 2000 | 9 |
| 10 | 2009 | 3 | |
| 11 | 2019 | 2 | |
| 12 | 2008 | 1 |
About Nancy Valente
Nancy Valente is a scholar working on Genetics, Pathology and Forensic Medicine, Radiology, Nuclear Medicine and Imaging, Epidemiology and Molecular Biology, having authored 12 papers that have together received 2.6k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (7 papers), Chronic Lymphocytic Leukemia Research (7 papers), Monoclonal and Polyclonal Antibodies Research (3 papers), Lung Cancer Treatments and Mutations (2 papers), Viral-associated cancers and disorders (2 papers), Neuroendocrine Tumor Research Advances (2 papers), Hemophilia Treatment and Research (1 paper) and Cancer Genomics and Diagnostics (1 paper). The work is most often cited by research in Genetics (768 citations), Hematology (803 citations), Cancer Research (520 citations), Pathology and Forensic Medicine (559 citations) and Immunology (642 citations). Nancy Valente has collaborated with scholars based in United States, Switzerland and France. Frequent co-authors include Michael Wenger, Amy Hobeika, H. Kim Lyerly, Alain Delcayre, Revati Shreeniwas, Michael A. Morse, Timothy M. Clay, Takuya Osada, Di‐Hwei Hsu and Jennifer Garst. Their work appears in journals such as Blood, Journal of Clinical Oncology, Journal of Translational Medicine, The Journal of Clinical Pharmacology and New England Journal of Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.